Balakuntalam S Kasinath Selected Research

3' Untranslated Regions (3' UTR)

1/2012

microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Balakuntalam S Kasinath Research Topics

Disease

31	Hypertrophy 10/2021 - 12/2002
19	Diabetic Nephropathies (Diabetic Nephropathy) 10/2021 - 12/2002
7	Fibrosis (Cirrhosis) 01/2022 - 12/2002
7	Neoplasms (Cancer) 10/2019 - 10/2009
7	Type 2 Diabetes Mellitus (MODY) 01/2016 - 08/2003
6	Hyperglycemia 10/2017 - 02/2007
5	Kidney Diseases (Kidney Disease) 01/2018 - 01/2014
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2014 - 08/2003
4	Hypoxia (Hypoxemia) 01/2022 - 10/2009
4	Kidney Neoplasms (Kidney Cancer) 07/2016 - 01/2012
3	Inflammation (Inflammations) 01/2021 - 02/2014
3	Glomerulonephritis 01/2021 - 12/2006
3	Albuminuria 12/2014 - 08/2011
3	Tuberous Sclerosis (Bourneville's Disease) 02/2012 - 12/2006
2	Carcinogenesis 01/2022 - 10/2010
2	Hyperinsulinism (Hyperinsulinemia) 01/2021 - 02/2014
2	Fatigue 01/2021 - 01/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2016 - 12/2013
2	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 06/2014 - 08/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Obesity 01/2021
1	Weight Gain 01/2021
1	Insulin Resistance 10/2019
1	Arteriolosclerosis 01/2019
1	Death (Near-Death Experience) 01/2016
1	Erectile Dysfunction 05/2015
1	Chronic Renal Insufficiency 01/2015
1	Hamartoma 02/2012
1	Body Weight (Weight, Body) 08/2011
1	Parkinson Disease (Parkinson's Disease) 08/2011
1	Autoimmune Diseases (Autoimmune Disease) 08/2011

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2002
22	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 02/2007
19	Mechanistic Target of Rapamycin Complex 1IBA 10/2021 - 02/2008
11	Fibronectins (Fibronectin)IBA 10/2021 - 11/2008
11	Phosphotransferases (Kinase)IBA 10/2020 - 12/2007
7	CollagenIBA 01/2022 - 08/2011
6	Insulin (Novolin)FDA Link 10/2019 - 02/2007
6	Sirolimus (Rapamycin)FDA Link 01/2016 - 12/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010 - 08/2003
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 08/2011
5	Mechanistic Target of Rapamycin Complex 2IBA 10/2021 - 02/2012
5	MicroRNAs (MicroRNA)IBA 10/2017 - 08/2011
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2017 - 07/2011
4	TOR Serine-Threonine KinasesIBA 06/2014 - 12/2006
4	Laminin (Merosin)IBA 02/2012 - 11/2008
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 02/2014
3	TensinsIBA 10/2017 - 07/2011
3	Streptozocin (Streptozotocin)FDA Link 12/2014 - 08/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 12/2002
3	trans-sodium crocetinate (crocetin)IBA 02/2012 - 10/2009
3	Messenger RNA (mRNA)IBA 01/2012 - 11/2008
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2014
2	Small Interfering RNA (siRNA)IBA 10/2021 - 01/2012
2	Plasminogen Activator Inhibitor 1IBA 10/2021 - 11/2014
2	GasotransmittersIBA 01/2021 - 01/2017
2	Insulin ReceptorIBA 01/2021 - 01/2018
2	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2019 - 10/2010
2	NexusIBA 01/2018 - 08/2017
2	sodium bisulfide (NaHS)IBA 01/2018 - 02/2012
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 10/2008
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2018 - 02/2012
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2016 - 07/2013
2	Tuberous Sclerosis Complex 2 ProteinIBA 07/2015 - 01/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2014 - 11/2010
2	ElementsIBA 01/2014 - 10/2009
2	Eukaryotic Initiation Factor-4EIBA 07/2013 - 02/2007
2	EnzymesIBA 02/2012 - 10/2010
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2011 - 10/2009
2	AMP-Activated Protein KinasesIBA 02/2007 - 12/2006
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	CholesterolIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Branched-Chain Amino AcidsIBA 01/2020
1	LipidsIBA 10/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 11/2016
1	Protein Kinases (Protein Kinase)IBA 04/2016
1	Tadalafil (Cialis)FDA Link 05/2015
1	Phosphodiesterase 5 InhibitorsIBA 05/2015
1	symmetric dimethylarginineIBA 01/2015
1	CatalaseIBA 11/2014
1	Toll-Like Receptor 4IBA 02/2014
1	Cyclin D1IBA 12/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2013
1	Cystatin CIBA 12/2012
1	CystathionineIBA 02/2012
1	LyasesIBA 02/2012
1	Collagen Type IV (Type IV Collagen)IBA 02/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2012
1	3' Untranslated Regions (3' UTR)IBA 01/2012
1	nephrinIBA 08/2011
1	NPHS2 proteinIBA 08/2011
1	Losartan (Cozaar)FDA LinkGeneric 12/2010
1	PD 123319IBA 12/2010
1	AlbuminsIBA 11/2010
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 10/2010

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2008
2	Renal Dialysis (Hemodialysis) 01/2021 - 01/2020